PharmiWeb.com - Global Pharma News & Resources

Biotech - Press Releases

Date Title Company
30-Aug-2024 Alfa Chemistry Reorganized Its Electroplating Intermediates Supply: Now Over 18 Categories Added Alfa Chemistry
30-Aug-2024 Alfa Chemistry's GPC Center Revolutionizes Analytical Methodologies with Rapid, Easy, and Efficient Services Alfa Chemistry
29-Aug-2024 European Commission approves RYBREVANT®▼ (amivantamab) in combination with chemotherapy for the treatment of adult patients with advanced EGFR-mutated non-small cell lung cancer after failure of prior therapy Janssen-Cilag International NV
29-Aug-2024 Leqembi® (lecanemab) Authorised for Early Alzheimer’s Disease in Great Britain Eisai Europe, Ltd
29-Aug-2024 Alfa Chemistry Announces Supply of Basic Filtration Products to Help Meet Various Filtration Challenges Alfa Chemistry
27-Aug-2024 BioPhorum acquires training organization Brookwood Global BioPhorum
27-Aug-2024 Microbiotica’s Microbiome Medicines in Melanoma and Ulcerative Colitis Gain Regulatory Approvals in EU and UK for Phase 1b Studies Microbiotica
27-Aug-2024 ConTIPI Medical Selects EVERSANA to Support U.S. Commercialization of Non-Surgical Medical Device ProVate for Women with Pelvic Organ Prolapse ConTIPI Medical Ltd
27-Aug-2024 European Commission approves Celltrion’s SteQeyma® (CT-P43), a biosimilar to Stelara® (ustekinumab), for the treatment of multiple chronic inflammatory diseases Celltrion
27-Aug-2024 UCB to Accelerate Innovation and Strategic Partnerships, Divesting Mature Product Portfolio in China UCB
27-Aug-2024 Medigene AG implements announced 2:1 share capital reduction and consolidation of the shares effective August 29, 2024 Medigene AG
27-Aug-2024 RedHill’s Opaganib Granted Orphan Drug Designation by the FDA for Childhood Cancer, Neuroblastoma RedHill Biopharma
27-Aug-2024 Regeneron Receives EC Approval for Ordspono (odronextamab) to Treat R/R Follicular Lymphoma or R/R Diffuse Large B-cell Lymphoma Regeneron
27-Aug-2024 Microbiotica’s Microbiome Medicines in Melanoma and Ulcerative Colitis Gain Regulatory Approvals in EU and UK for Phase 1b Studies Microbiotica
27-Aug-2024 Transgene — Preclinical Proof-of-Concept Data of Oncolytic Virus TG6050 Published in JITC Transgene
27-Aug-2024 New drug trial offers hope to 200,000 people with ‘hidden’ lung condition EMBARC
27-Aug-2024 InsightRX Announces the release of InsightRX GEMINI(SM) InsightRX
27-Aug-2024 Brightflow welcomes Sophie Humbert as CEO Andrew Lloyd Associates
27-Aug-2024 Bio-Sourcing Andrew Lloyd Associates
24-Aug-2024 CD Formulation Announces Ability to Test the Contact Angle of Pharmaceutical Excipients for Better Selection of Surfactants CD Formulation